If youre serious about safe, proven results, the safest move is working with a provider who can prescribe the real thing
More direct evidence for GLP-1 modulating dopamine transmission comes from a study showing that a GLP-1 agonist also reduced phasic dopamine response in the VTA in rats (Konanur et al., 2020)
As Aons own researchers put it, that is not just a win for patients
This article looks at the difference between compounded semaglutide and Ozempic, as well as the safety and effectiveness of compounded semaglutide
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
This means retatrutide can directly target liver fat in a way that other medications can't